BARCLAYS PLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 52 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$2,873
+2.9%
112,467
+15.5%
0.00%0.0%
Q2 2023$2,792
+34.8%
97,355
+12.6%
0.00%
+100.0%
Q1 2023$2,071
+12.6%
86,433
-20.3%
0.00%0.0%
Q4 2022$1,839
-99.9%
108,496
-10.1%
0.00%
-50.0%
Q3 2022$1,790,000
+155.0%
120,743
+170.5%
0.00%
Q2 2022$702,000
+631.2%
44,637
+1146.8%
0.00%
Q1 2022$96,000
-94.9%
3,580
-93.0%
0.00%
Q4 2021$1,898,000
+248.9%
51,246
+349.6%
0.00%
Q3 2021$544,000
+365.0%
11,397
+231.6%
0.00%
Q2 2021$117,000
-91.7%
3,437
-89.9%
0.00%
-100.0%
Q1 2021$1,409,000
-57.1%
34,131
-55.0%
0.00%
-50.0%
Q4 2020$3,288,000
+786.3%
75,806
+775.0%
0.00%
Q3 2020$371,000
-74.9%
8,664
-72.6%
0.00%
-100.0%
Q2 2020$1,477,000
+4002.8%
31,638
+1083.2%
0.00%
Q1 2020$36,000
+800.0%
2,674
+664.0%
0.00%
Q4 2019$4,000
+300.0%
350
+386.1%
0.00%
Q3 2019$1,000720.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2019
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders